AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting

Phase 1

Phase 2

AGN-193408AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Sponsor:

AbbVie

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

AGN-193408 SR

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by AbbVie on 2025-03-24.